Neomorph

Neomorph, Inc. is a venture-backed, clinical-stage biotechnology company headquartered at 5590 Morehouse Drive in San Diego, California, founded in 2020 to design molecular glue degraders — small molecules that bind an E3 ubiquitin ligase, reshape it into a new "neomorphic" surface, and recruit disease-causing proteins to the proteasome for destruction. The approach targets the roughly 85% of the human proteome considered undruggable by conventional small molecules because it needs no traditional binding pocket. Neomorph's platform reaches beyond cereblon to hundreds of E3 ligases and multiple proprietary degrons, which the company describes as the largest proprietary molecular glue target space in the field. Its lead programme, NEO-811, targets ARNT/HIF-1β in clear cell renal cell carcinoma and entered a Phase 1/2 trial in February 2026; the rest of the pipeline spans undisclosed solid tumors plus partnered oncology/immunology, neurology and cardiometabolic/rare disease targets. The company closed a $109 million Series A in December 2020 and a $100 million Series B in April 2026, and runs multi-target discovery collaborations with Novo Nordisk (February 2024), Biogen (October 2024) and AbbVie (January 2025). Philip Chamberlain, DPhil is CEO and Robert J. Hugin was appointed Chairman of the Board in May 2026. Neomorph runs no developer program and publishes no product API, developer portal, API reference, SDK or pricing. The only machine-readable surface reachable without credentials is the WordPress REST content API behind neomorph.com, catalogued here.

Neomorph publishes 1 API contract indexed on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Targeted Protein Degradation.

Neomorph’s developer surface includes product news, authentication, and 26 more developer resources.

🌐 Visit website 📡 Source on GitHub

19.3/100 emerging ▬ flat Agent 9/100 agent aware Front door AI 1/6 silent saas Full breakdown ↓
scored 2026-10-09 · rubric v0.23.0

AccessOpen

2 published contracts

Company Biotechnology Pharmaceuticals Drug Discovery Targeted Protein Degradationmolecular-glueOncology Immunology Rare Disease Clinical Trials Life Sciences content-api

Kin Score

Kin Score How this is scored →
scored 2026-10-09 · rubric v0.23.0

Composite quality — 19.3/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 3.9 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 1.9 / 10

Discoverability 5.5 / 9

Regulatory Posture 3.6 / 15

Agent readiness — 9/100 · agent aware

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 10 / 10

Idempotency 0 / 9

Stable Error Semantics 8 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 7 / 7

Typed Event Surface 0 / 6

Agent Skills 5 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics does not apply to this provider. The published contracts declare no write operations, and a read-only API cannot create-or-update. The facet is excluded from this provider's denominator entirely — not scored zero. A reference or data API is not deficient for being unable to upsert.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/neomorph: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

Neomorph Website (WordPress REST)

The public WordPress REST API (wp-json) of the Neomorph website at neomorph.com: the route index of the site's content management system, catalogued as one site surface rather t...

Pricing Plans 1

Published pricing tiers and plan structures.

Neomorph Plans Pricing

0 plans

PLANS

Rate Limits 1

Documented rate limits and quota policies.

Neomorph Rate Limits

0 limits

RATE LIMITS

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Neomorph Authentication

0 schemes

SECURITY

Neomorph Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

AgentSkill

AgentSkill

Design & Contract 5

Pagination, idempotency, versioning, errors, and events

Conventions

Conformance

ErrorCatalog

Lifecycle

DataModel

Access & Security 2

Authentication, authorization, and security posture

Authentication

Authentication

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

Contact

Contact

RateLimits

RateLimits

Commercial 3

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Plans

Plans

Company 7

The organization behind the API

Website

About

News

BlogRSS

Careers

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 7

Properties that don't map to a standard resource type

Platform

Pipeline

Publications

PatientResources

CookiePolicy

Accessibility

SecondaryMarket

Scroll for all 7

Source (apis.yml)

aid: neomorph
name: Neomorph
description: Neomorph, Inc. is a venture-backed, clinical-stage biotechnology company headquartered at 5590 Morehouse Drive
  in San Diego, California, founded in 2020 to design molecular glue degraders — small molecules that bind an E3 ubiquitin
  ligase, reshape it into a new "neomorphic" surface, and recruit disease-causing proteins to the proteasome for destruction.
  The approach targets the roughly 85% of the human proteome considered undruggable by conventional small molecules because
  it needs no traditional binding pocket. Neomorph's platform reaches beyond cereblon to hundreds of E3 ligases and multiple
  proprietary degrons, which the company describes as the largest proprietary molecular glue target space in the field. Its
  lead programme, NEO-811, targets ARNT/HIF-1β in clear cell renal cell carcinoma and entered a Phase 1/2 trial in February
  2026; the rest of the pipeline spans undisclosed solid tumors plus partnered oncology/immunology, neurology and cardiometabolic/rare
  disease targets. The company closed a $109 million Series A in December 2020 and a $100 million Series B in April 2026,
  and runs multi-target discovery collaborations with Novo Nordisk (February 2024), Biogen (October 2024) and AbbVie (January
  2025). Philip Chamberlain, DPhil is CEO and Robert J. Hugin was appointed Chairman of the Board in May 2026. Neomorph runs
  no developer program and publishes no product API, developer portal, API reference, SDK or pricing. The only machine-readable
  surface reachable without credentials is the WordPress REST content API behind neomorph.com, catalogued here.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: true
  label: Hosted service · you call their endpoint
  confidence: high
  source:
  - openapi
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: open
  trial: false
  try_now: false
  public: true
  label: Open access
  confidence: medium
  source:
  - authentication
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://neomorph.com/wp-content/uploads/2026/03/OG-Neomorph.png
url: https://raw.githubusercontent.com/api-evangelist/neomorph/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Targeted Protein Degradation
- molecular-glue
- Oncology
- Immunology
- Rare Disease
- Clinical Trials
- Life Sciences
- content-api
tags_raw:
- Company
- biotechnology
- pharmaceuticals
- drug-discovery
- targeted-protein-degradation
- molecular-glue
- oncology
- immunology
- rare-disease
- clinical-trials
- life-sciences
- content-api
apis:
- aid: neomorph:neomorph-com-website-wordpress-rest
  name: Neomorph Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the Neomorph website at neomorph.com: the route index of the site''s
    content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://neomorph.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://neomorph.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://neomorph.com/
- type: About
  url: https://neomorph.com/about-us/
- type: Platform
  url: https://neomorph.com/platform/
- type: Pipeline
  url: https://neomorph.com/pipeline/
- type: Publications
  url: https://neomorph.com/publications/
- type: PatientResources
  url: https://neomorph.com/patients/
- type: News
  url: https://neomorph.com/news/
- type: BlogRSS
  url: https://neomorph.com/feed/
- type: Careers
  url: https://neomorph.com/careers/
- type: Contact
  url: https://neomorph.com/contact/
- type: PrivacyPolicy
  url: https://neomorph.com/privacy-policy/
- type: TermsOfService
  url: https://neomorph.com/terms-of-use/
- type: CookiePolicy
  url: https://neomorph.com/cookie-policy/
- type: Accessibility
  url: https://neomorph.com/accessibility-statement/
- type: LinkedIn
  url: https://www.linkedin.com/company/neomorph-llc/
- type: Twitter
  url: https://x.com/neomorphinc
- type: SecondaryMarket
  url: https://forgeglobal.com/neomorph_stock/
- type: Authentication
  url: authentication/neomorph-authentication.yml
- type: Conventions
  url: conventions/neomorph-conventions.yml
- type: Conformance
  url: conformance/neomorph-conformance.yml
- type: ErrorCatalog
  url: errors/neomorph-problem-types.yml
- type: Lifecycle
  url: lifecycle/neomorph-lifecycle.yml
- type: DataModel
  url: data-model/neomorph-data-model.yml
- type: RateLimits
  url: rate-limits/neomorph-rate-limits.yml
- type: Plans
  url: plans/neomorph-plans-pricing.yml
- type: DomainSecurity
  url: security/neomorph-domain-security.yml
- type: LLMsTxt
  url: llms/neomorph-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-26'
  status: enriched
  artifacts_added: 28
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/neomorph"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/neomorph/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/neomorph/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.